Nektar Therapeutics (NKTR) EBITDA Margin Growth (3y) (2013 - 2026)
Nektar Therapeutics (NKTR) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 9,942.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 7,794.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Nektar Therapeutics | 1.76 Bn | 1.19 Bn | 3.16 Mn | 26,425.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26,425.00 |
| Dec 31, 2025 | 11,138.00 |
| Sep 30, 2025 | -3,879.00 |
| Jun 30, 2025 | 38,386.00 |
| Mar 31, 2025 | 4,382.00 |
| Dec 31, 2024 | 50,066.00 |
| Sep 30, 2024 | 31,346.00 |
| Jun 30, 2024 | 17,710.00 |
| Mar 31, 2024 | 29,889.00 |
| Dec 31, 2023 | 33,161.00 |
| Sep 30, 2023 | 15,730.00 |
| Jun 30, 2023 | -8,775.00 |
| Mar 31, 2023 | -35,960.00 |
| Dec 31, 2022 | 8,553.00 |
| Sep 30, 2022 | 10,810.00 |
| Jun 30, 2022 | -23,211.00 |
| Mar 31, 2022 | -4,195.00 |
| Dec 31, 2021 | -19,964.00 |
| Sep 30, 2021 | -10,054.00 |
| Jun 30, 2021 | -47,851.00 |